Imaging advocate reminds patients and providers to check for metal in masks before MRI exams

The Medical Imaging & Technology Alliance is reminding patients and providers to make sure there is no metal in masks being worn during MRI exams, the imaging advocate warned on Friday.

On Dec. 7, the U.S. Food & Drug Administration issued a safety notification warning patients not to wear face masks with metal parts during MR imaging after it received a report of an individual’s face being burned. MITA recently sent out an email to remind doctors and patients to check for small metallic parts before such exams.

“The COVID-19 pandemic impacts the way diagnostic imaging examinations are performed,” MITA said in its statement. “The U.S. FDA issued a safety notification to remind patients and providers not to wear any metal during the MR examination. MITA fully supports this reminder and reinforces the instructions for use with MR systems.”

Furthermore, clothes should be checked for metal pieces and strips of woven microfabric material prior to MRIs. MITA recommends using hospital-supplied gowns and masks in all instances and to check with mask manufacturers to ensure no metallic nanoparticles or material is embedded into masks.

It all started after the FDA received an official injury report detailing how a patient wore a face mask with metal during a 3 Tesla neck scan. That person sustained burns consistent with the shape of a mask, according to the federal health organization.

Should a burn occur, doctors are encouraged to immediately report the injury to the FDA to help improve its patient safety measures.

Read the FDA’s entire safety guidance here.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.